DAE HWA Pharmaceutical Co. Ltd (067080) — Net Asset Quality Index
DAE HWA Pharmaceutical Co. Ltd (067080) has a Net Asset Quality Index of 38.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩222.33 Billion minus total liabilities of ₩137.27 Billion yields net assets of ₩85.06 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does DAE HWA Pharmaceutical Co. Ltd carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
DAE HWA Pharmaceutical Co. Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how DAE HWA Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 38.3%, representing net assets of ₩85.06 Billion against total assets of ₩222.33 Billion KRW. For live market cap and overall valuation, see market value of DAE HWA Pharmaceutical Co. Ltd.
Annual Net Asset Quality Index for DAE HWA Pharmaceutical Co. Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 067080 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 37.5% | ₩79.14 Billion | ₩210.86 Billion | ₩131.72 Billion | ▲ +2.6 pp |
| 2024 | 35.0% | ₩72.00 Billion | ₩205.88 Billion | ₩133.89 Billion | ▲ +1.6 pp |
| 2023 | 33.4% | ₩73.23 Billion | ₩219.16 Billion | ₩145.93 Billion | ▼ -5.8 pp |
| 2022 | 39.2% | ₩77.99 Billion | ₩199.06 Billion | ₩121.06 Billion | ▼ -5.7 pp |
| 2021 | 44.9% | ₩79.67 Billion | ₩177.38 Billion | ₩97.70 Billion | ▼ -1.9 pp |
| 2020 | 46.8% | ₩81.98 Billion | ₩175.05 Billion | ₩93.07 Billion | ▼ -0.9 pp |
| 2019 | 47.8% | ₩79.35 Billion | ₩166.15 Billion | ₩86.80 Billion | ▲ +0.3 pp |
| 2018 | 47.4% | ₩76.88 Billion | ₩162.06 Billion | ₩85.17 Billion | ▲ +1.1 pp |
| 2017 | 46.4% | ₩76.75 Billion | ₩165.47 Billion | ₩88.72 Billion | ▲ +3.4 pp |
| 2016 | 43.0% | ₩66.15 Billion | ₩153.80 Billion | ₩87.65 Billion | ▼ -6.0 pp |
| 2015 | 49.0% | ₩61.06 Billion | ₩124.61 Billion | ₩63.55 Billion | ▲ +1.8 pp |
| 2014 | 47.2% | ₩58.51 Billion | ₩124.07 Billion | ₩65.57 Billion | ▼ -3.7 pp |
| 2013 | 50.9% | ₩62.03 Billion | ₩121.87 Billion | ₩59.84 Billion | ▲ +3.7 pp |
| 2012 | 47.2% | ₩61.39 Billion | ₩130.19 Billion | ₩68.80 Billion | ▲ +5.1 pp |
| 2011 | 42.0% | ₩56.99 Billion | ₩135.58 Billion | ₩78.60 Billion | — |